Product Details:
| Strength | 420 mg |
| Pack Size | 14 ml |
| Manufacturer | Hetero Drugs |
Perzea 420 mg Injection is an anti-cancer medication containing the active ingredient Pertuzumab (30 mg/mL), designed for intravenous infusion. It is utilized to treat HER2-positive breast cancer, often in combination with trastuzumab and docetaxel. It works by targeting cancer cells to inhibit their growth, particularly in metastatic or early-stage, high-risk cases.